InsidersTradesSigma
Follow the 众生药业 share price and the full management transaction log of the company, a listed issuer based in China. Shares are quoted on the CN market, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 众生药业 has logged 3 public disclosures. Market capitalisation: €22.3bn. The latest transaction was filed on 26 April 2024 (Purchase). Among the most active insiders: 陈永红. All data is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
众生药业是一家在健康和制药领域运营的公司，在深圳证券交易所上市。该公司专注于创新药物的研发和生产。